Burning Rock Biotech Limited (BNR) Misses Q3 EPS by 39c

Burning Rock Biotech Limited (NASDAQ: BNR) reported Q3 EPS of (RMB1.71), RMB0.39 worse than the analyst estimate of (RMB1.32). Revenue for the quarter came in at RMB127.6 million versus the consensus estimate of RMB198 million.

For earnings history and earnings-related data on Burning Rock Biotech Limited (BNR) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• SuperCom (SPCB) Tops Q3 EPS by 43c
• Ideal Power (IPWR) Tops Q2 EPS by 2c